US FDA News: FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C

FDA approved a supplemental application for Epclusa to treat HCV in children with any of the six HCV genotypes.
Read more: FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C